Hypertension is an important public health issue because of its association with a number of significant diseases and adverse outcomes. However, there are important ethnic differences in the pathogenesis and cardio-/cerebrovascular consequences of hypertension. Given the large populations and rapidly aging demographic in Asian regions, optimal strategies to diagnose and manage hypertension are of high importance. Ambulatory | 1251 KARIO et Al.
| INTRODUC TI ON
Hypertension is a significant public health issue, largely due to the contribution it makes to the risk of other serious diseases, including cardiovascular disease and stroke. 1, 2 However, there are important ethnic differences in the pathogenesis and cardiovascular consequences of hypertension. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] With large populations and the rapidly aging population demographic in Asian countries, the increasing burden of hypertension and associated comorbidities will have a growing and substantial negative economic and social impact in the region. 6, [13] [14] [15] Therefore, optimizing strategies to detect and manage hypertension is of utmost importance.
Major international guidelines highlight the importance of outof-office blood pressure (BP) monitoring in the diagnosis and management of hypertension. 13, [16] [17] [18] [19] [20] [21] [22] [23] The two main options available are home blood pressure monitoring (HBPM) and ambulatory blood pressure monitoring (ABPM). Recommendations for the application of HBPM in Asian contexts are available, 24 but corresponding guidelines for the region-specific use of ABPM are lacking.
This document summarizes the evidence-based consensus recommendations of an expert panel on ABPM convened for Asia by the Hypertension, brain, cardiovascular and renal Outcome Prevention and Evidence in Asia (HOPE Asia) Network. It is anticipated that these recommendations will help guide clinical practice, contribute to the optimization of BP monitoring, and thus improve the management of hypertension in the region, with the ultimate goal of reducing the risk of cardiovascular events.
| MATERIAL S AND ME THODS
The expert panel's consensus recommendations were the output of a HOPE Asia Network meeting convened in Beijing, China, on September 21, 2018 during the 2018 Scientific Meeting of the International Society of Hypertension. The recommendations were based on a review of evidence from randomized controlled trials (RCTs), meta-analyses, and other relevant data on ABPM. Priority was given to data sourced from the Asia region to ensure that the recommendations would be applicable to a diverse range of populations in Asia. In cases where it was necessary to look at evidence generated outside Asia, the expert panel used their clinical experience and expertise to analyze the data in the context of hypertension management in their region.
| RE SULTS
The expert panel identified key items in relation to ABPM for discussion and generated consensus statements. These statements, their recommendations, and relevant supporting literature are discussed below and summarized in Consensus Tables A1-A11. Classification of recommendations and levels of evidence are shown in Table 1 .
| Advantages and limitations of ABPM vs office and home BP in clinical practice
Ambulatory blood pressure monitoring provides several pieces of information that cannot be obtained from other methods of BP measurement (Consensus Table A1 ). These include a greater number of readings, the ability to estimate mean 24-hour BP, assessment of BP variability (BPV; particularly short-term variability), and better prediction of cardiovascular morbidity and mortaliy. 17 In addition, the readings obtained relate to an individual's BP in their usual daily environment, providing an indication of the effects of environmental and emotional factors on BP. 17, 25 ABPM also appears useful for detecting ambulatory episodes of hypotension. 26, 27 The characteristics of ABPM compared with HBPM and office-based BP measurement are shown in Table 2 .
A number of studies have shown that 24-hour ambulatory BP correlates better with cardiovascular outcomes than office BP. In the Systolic Hypertension in Europe (Syst-Eur) trial of untreated elderly patients with isolated systolic hypertension, ambulatory systolic BP (SBP) provided prognostic information on cardiovascular risk that was additional to that provided by clinic BP values. 28 In a general Funding information Editorial and writing support was provided by Nicola Ryan, independent medical writer, funded by Pfizer. The meeting during which these recommendations were formulated and discussed was made possible by an unrestricted educational grant from Pfizer and was supported by A&D. However, the recommendations were developed by the HOPE Asia Network independently of Pfizer and A&D. blood pressure monitoring (ABPM) is an important out-of-office blood pressure (BP) measurement tool that should play a central role in hypertension detection and management. The use of ABPM is particularly important in Asia due to the specific features of hypertension in Asian patients, including a high prevalence of masked hypertension, disrupted BP variability with marked morning BP surge, and nocturnal hypertension. This HOPE Asia Network document summarizes region-specific literature on the relationship between ABPM parameters and cardiovascular risk and target organ damage, providing a rationale for consensus-based recommendations on the use of ABPM in Asia. The aim of these recommendations is to guide and improve clinical practice to facilitate optimal BP monitoring with the goal of optimizing patient management and expediting the efficient allocation of treatment and health care resources. This should contribute to the HOPE Asia Network mission of improving the management of hypertension and organ protection toward achieving "zero" cardiovascular events in Asia. population from Ohasama, Japan, ambulatory BP values, especially daytime BP, were a stronger predictor of stroke risk than clinic BP. 29 In the same population, both daytime and nighttime ambulatory BP values were closely associated with the risk of silent cerebrovascular lesions (detected on magnetic resonance imaging). 30 The information obtained from ABPM is complementary to that generated by HBPM, and rational combination of these two approaches in clinical practice is recommended. 17, 18, 23 Cost (including reimbursement) and accessibility are potential issues that could limit the use of ABPM in some settings and/or countries, [31] [32] [33] although longer term savings are likely to offset the short-term costs of ABPM use. 17 ABPM can be inconvenient for patients so acceptability is also potentially problematic. 32, 33 In addition, issues with the reliability of ABPM devices have been raised. 31 Cuff inflation during ABPM is associated with some discomfort, but this does not appear to increase heart rate. 34 ABPM use needs to be standardized to improve reproducibility.
| Measurement schedule and assessment of ABPM parameters
ABPM can be complex for patients, and adequate time is needed to provide appropriate and thorough education, including informing patients that cuff inflation might be associated with some discomfort (Consensus Table A2 ). 17 The use of an ABPM device that has been validated against accepted international standards, with associated software providing the data of interest, is recommended. 17 This should at least include presentation of all BP readings showing daytime and nighttime windows with an indication of normal BP, average SBP, diastolic BP (DBP) and heart rate, the percentage decline in nocturnal SBP and DBP, and summary statistics for time-weighted average SBP, DBP and heart rate for the 24-hour period, daytime, and nighttime, with standard deviations and number of valid BP readings. 17 To obtain satisfactory ABPM data, the use of the non-dominant arm is preferred and an appropriate cuff should be provided. 17 Measurements should be taken every 15-30 minutes during the day and every 30-60 minutes at night, the ABPM recording needs to provide a minimum of 20 valid daytime and at least 7 valid nighttime measurements, and at least 70% of the expected 24-hour readings need to be valid. Collection of ABPM data on a normal workday (rather than a weekend or rest day) will provide a more typical BP profile. 25 
TA B L E 1 Classes of recommendation and levels of evidence

Classes of recommendations
Class I
Evidence and/or general agreement that a given treatment or procedure is beneficial, useful, effective (is recommended/is indicated)
Class IIa
Weight of evidence/opinion is in favor of usefulness/efficacy (should be considered)
Class IIb
Usefulness/efficacy is less well established by evidence/opinion (may be considered)
Class III
Evidence or general agreement that the given treatment or procedure is not useful/effective, and in some cases may be harmful (is not recommended) Figure 1 ). The diary card-based approach is preferable because the use of arbitrary definitions does not account for inter-individual variation in bedtime and time spent in bed, and the 24-hour clock-based definitions are only reliable in individuals who go to bed and arise within well-defined periods. 35 This means that important data on the white-coat window, the early phase of nighttime sleep where dipping might be most marked, and the early morning BP surge might be missed.
Levels of evidence
| Definition of ABPM hypertension and BP goals
ABPM provides information on a number of different BP indices, including 24-hour, morning, daytime, and nighttime BP ( Figure 1 ; Consensus Table A3 ). Guidelines recommend the use of out-of-office BP monitoring, including ABPM, to facilitate the diagnosis of hypertension, including detection of white-coat hypertension (WCH) and masked hypertension (MH). 13, 16, [18] [19] [20] [21] [22] [23] [36] [37] [38] ABPM is the gold standard for diagnosing hypertension and assessment of 24-hour BP, and has better sensitivity and specificity than either clinic or home BP measurements for the diagnosis of hypertension. 39
| Thresholds for defining hypertension and monitoring response to treatment
ABPM thresholds for diagnosing hypertension and defining achievement of BP control during antihypertensive therapy have been defined (Consensus Table A3 ). Absolute values for ambulatory BP thresholds are lower than those for clinic or office BP ( However, the predictive value of these levels needs to be confirmed in future outcome studies.
The definition of BP control can vary, with lower thresholds defined to provide strict control of BP (Consensus Table A3 ). It is important to know whether prescribed treatment has restored BP to within the normal range throughout the 24-hour treatment period, and the only way to reliably achieve this is by repeated ABPM. Once BP control has been achieved and documented, periodic reassessment using ABPM will ensure the maintenance of 24-hour BP control.
| White-coat hypertension
The use of ABPM allows identification of patients who have WCH (elevated office BP and normal out-of-office BP; Figure 2 ). European recommendations suggest that individuals with suspected WCH should have the diagnosis confirmed using ABPM within 3-6 months after elevated office BP is detected, with follow-up ABPM performed annually to ensure that progression to sustained hypertension is detected. 17 In contrast, the Canadian diagnostic algorithm recommends performing HBPM or ABPM after the first clinic visit so that patients with WCH can be identified early. 40 Accurate diagnosis of WCH is important to avoid the costs and potential side effects associated with unnecessary antihypertensive pharmacotherapy. ABPM data showing a normotensive dip in a patient with WCH are shown in Figure A1 . Both this and a normal pattern ( Figure A2 ) show normal diurnal BP rhythm with a nighttime BP fall of 10%-19% compared with daytime BP.
| Masked hypertension
Masked hypertension is defined as a normal office BP and an elevated BP on out-of-office readings ( Figure 2 ). ABPM has been described as the first-choice diagnostic method for detecting MH. 41 In individuals with normal office BP, MH could be characterized by elevated morning, daytime, and/or nighttime BP on ABPM ( Figure 3 ). However,
given that only about 10%-20% of patients with normotension based on office BP have MH, 42 referral of all those with normal office BP for ABPM is not practical. It is therefore suggested that the use of ABPM should be targeted to patient groups more likely to have MH, including males, older individuals, smokers, and those with a high body mass index (BMI), diabetes mellitus, or high serum cholesterol levels. 43 According to the latest US guidelines, adults with untreated office BP values consistently between 120/75 and 129/79 mm Hg are those who should be referred for out-of-office BP screening. 22 Identification of MH is important because of the increased risk of cardiovascular disease and target organ damage that accompanies this form of hypertension. [44] [45] [46] 
| Clinical indications for ABPM
ABPM is considered the state-of-the art technology for BP measurement, and its use is endorsed by major international guidelines for North America, 22, 37, 47 Europe, 16, 17, 23 Japan, 21 China, 48 and
Taiwan (Consensus Table A4 ). 13 ABPM plays a key role in the diagnosis and management of hypertension. It should be performed in individuals who show unstable and/or variable BP on office or home measurements because these patients are more likely to have WCH or MH. 17 In addition, unstable BP could also indicate poor control during antihypertensive therapy. 17 The use of ABPM in patients with resistant hypertension allows categorization of patients as having true resistance rather than white-coat resistance (seen in up to one-third of patients with resistant hypertension based on office BP alone 49, 50 ), allowing appropriate targeting of additional therapeutic interventions. Although there are some regional variations in specific recommendations (see Section 12) , key indications for the use of ABPM are summarized in Table 5 . 
| Assessment and definition of disrupted diurnal BP pattern
Although there has been a tendency for guidelines to focus on ABPM daytime pressures, BP reflects the hemodynamic state and is not a static phenomenon (Consensus Table A5 Table 3 . The expected physiological fall in nighttime BP is ≧10% (dipping). ABPM data for a hypertensive dipper (normal diurnal variation) with an appropriate fall in nighttime BP (<20%, ≧10%) are shown in Figure A3 . A reduction of <10% in BP at night is defined as non-dipping. Figure A4 shows a non-dipper ABPM pattern, with a reduced nighttime BP fall (10%, ≧0%).
Extreme dipping ( Figure A5 ) refers to patients who show a marked nocturnal fall (≧20%) in SBP and/or DBP, or have a night/day SBP or DBP ratio of <0.8. 18 Extreme dipping has been associated with a significant increase in the risk of intracerebral hemorrhage compared to patients with a physiological fall in nighttime BP. 52 Patients with a riser, or reverse dipping, pattern show an increase in BP during sleeping hours to levels that may be higher than those during the day. 53 The ABPM profile for a riser pattern with higher nighttime vs daytime BP is shown in Figure A6 . Nocturnal hypertension (BP ≥ 120/70 mm Hg) may indicate the presence of comorbidities such as obstructive sleep apnea (OSA), and the riser pattern of nighttime BP is associated with a particularly poor prognosis with respect to the occurrence of stroke and cardiac events. 54
| Assessment and definition of disrupted shortterm blood pressure variability
Put simply, BPV refers to variations in BP over time (Consensus Table A6 ). There are a number of different components to BPV, including diurnal or circadian (as described above), short-term, and 
| 24-hour BP characteristics of specific diseases
Sleep is an important determinant of the diurnal variation in BP, with BP usually decreasing during sleep (Consensus Table A7 ). Patients with OSA often have disrupted sleep, and the prevalence of arterial hypertension and MH in this group is high. 57 Common ABPM findings in patients with OSA include non-dipping profile, morning BP surge, and increased BPV. 58, 59 Correlations between the evening-to-morning BP difference and the severity of OSA have been reported. 60 76, 77 In addition, non-dipping is common in diabetes 75, 76, 78, 79 and this is not detected on office BP measurement, meaning that ABPM has an important role. Masked hypertension is also more common in patients with vs without diabetes and appears to increase the risk of target organ damage. 80 Patients with chronic kidney disease (CKD) have a high prevalence of MH, which is a significant predictor of progression to endstage renal disease and total mortality. [81] [82] [83] [84] Abnormal ABPM findings in CKD include nocturnal non-dipping 85 and increased BPV, 85, 86 both of which increase in prevalence as the severity of CKD increases. 87 In addition, non-dipping in patients with CKD has been associated with the rate of decline in renal function. 88, 89 Various other underlying causes of secondary hypertension, including renovascular hypertension, primary aldosteronism, Cushing syndrome, and pheochromocytoma, are associated with a higher prevalence of non-dipper pattern and nocturnal hypertension. 90, 91 Specific agents such as non-steroidal anti-inflammatory drugs (NSAIDs) and Kanzo [liquorice] increase the circulating volume, resulting in a non-dipping pattern and nocturnal hypertension. 92-94
| Asian characteristics of the 24-hour BP profile
There are a number of important and clinically relevant features of hypertension in Asian populations (Consensus Table A8 ). In terms of predisposing factors, both salt sensitivity and salt intake are higher, and pre-hypertension develops at a lower BMI and with smaller BMI increments in Asians compared with European populations. 9, 10 In addition, Asians are likely to have a genetic predisposition to salt-sensitive gene polymorphism of the renin-angiotensin system. 10
The prevalence of masked (uncontrolled) hypertension, excessive morning BP surge and morning hypertension, and nocturnal hypertension is higher in Asians than in Europeans (Table 6 ). 56 96 In another study, the sleep-trough morning BP surge in Japanese patients with untreated hypertension was significantly higher than that in similar patients from Europe, independent of age, 24-hour BP and lowest nocturnal BP (40.1 vs 23.0 mm Hg; P < .001). 95 This may be due to the strong link between sympathetic nervous system activity and salt intake, 100 and the fact that dietary salt intake is higher in Asian than in Western populations. In addition, data from the international Ambulatory Blood Pressure Registry:
Telemonitoring of Hypertension and Cardiovascular Risk Project (ARTEMIS) showed that MH and masked uncontrolled hypertension were diagnosed more often in Asia than in any other region. 98 This 
The complications of hypertension also show ethnic variations. In
Western subjects, coronary heart disease (CHD) is a more common complication of hypertension, whereas stroke occurs at a higher rate than CHD in Asians. 8, 12 The development of both stroke and non-ischemic heart failure is closely related to the presence of hypertension, and both of these comorbidities are more common in Asian than in Western countries. 4, 5 In addition, the slope of the relationship between increasing BP and cardiovascular events, especially stroke, is steeper in Asians than in Westerners. 4,102-104 Furthermore, data from the Asia Pacific Cohort Studies Collaboration showed that there was a stronger relationship between BP and cardiovascular disease in Asian patients than in those from Australia and New Zealand. 7, 11 Strict BP control throughout the 24-hour period is important for all patients, but this is particularly the case in Asia. 3 Given the greater effect of BP reductions on stroke and heart failure vs CHD, 105 and the higher rate of these events in Asians, 8, 12 the beneficial effects of BP lowering may be more marked in Asian compared with Western populations. 4 Treatment with a long-acting calcium channel blocker (CCB)
has been shown to be effective for lowering office, home morning, and 24-hour ambulatory BP, and reducing exaggerated BPV, independently of salt intake and salt sensitivity. [106] [107] [108] [109] This approach is therefore well suited to the characteristics of Asian patients with hypertension. The use of ABPM is required to evaluate the effects of antihypertensive treatment on 24-hour BP and the BPV profile.
Increased home BPV and abnormal 24-h BP patterns
Detected by determination of standard deviation, coefficient of variation, average real variability, morning-evening difference, or peak home BP
Advanced target organ damage
Including left ventricular hypertrophy, advanced vascular disease, heart failure with preserved ejection fraction, chronic kidney disease, cognitive dysfunction
Suspected masked hypertension
Nocturnal hypertension (related to obstructive sleep apnea, diabetes and/or chronic kidney disease) or daytime hypertension (related to stress or smoking habit)
Suspected white-coat hypertension
To exclude the presence of persistent hypertension and avoid unnecessary treatment 
| ABPM parameters predicting cardiovascular outcomes
The risk of hypertensive cardiovascular complications appears to correlate better with 24-hour BP measured using ABPM than with office BP measurements, both in the general population and in the elderly (Consensus Table A8 ). [110] [111] [112] Literature supporting the relationship between various ABPM parameters and cardiovascular risk or target organ damage is summarized in the next two sections and detailed in Table 7 .
| Morning BP surge
Early morning BP surge is associated with an increased risk of cardiovascular and cerebrovascular adverse events, especially hemorrhagic stroke. 52, 95, [113] [114] [115] [116] [117] [118] In a study of 340 ABPM subjects from China, the proportion of those showing an early morning BP surge was greater among individuals with hypertension vs normotension, and this surge was significantly and independently associated with the occurrence of stroke and cardiovascular events. 119 Japanese ABPM data from the Jichi Medical University School of Medicine (JMS-ABPM study) showed that the incidence of stroke events in the morning hours was higher in subjects with vs without an exaggerated morning BP surge, and persisted after adjust- In a meta-analysis of seven prospective studies evaluating morning surge in a total of 14 133 patients over a mean follow-up of 7.1 years, excess sleep-trough morning surge was a strong predictor of future all-cause mortality (relative risk 1.29; P = .001). 122 Another meta-analysis of 17 studies did not find any clear evidence for the impact of preawaking morning BP surge on prognosis. However, using a continuous scale, which has more power to detect an association, there was evidence that a 10 mm Hg increase in morning surge was related to an increased risk of stroke (hazard ratio 1.11, 95%
confidence interval 1.03-1.20). 123
| Non-dipping
Non-dipping is particularly common in patients with diabetes mellitus (prevalence of up to 30%) 54, 78 and has been linked to increased risk of target organ damage, stroke, cardiovascular events, and mortality in some studies. 78 In the study where non-dipping was first defined, patients with a non-dipping BP profile had a significantly higher stroke risk. 134 The results of some subsequent studies support a link between non-dipping status (elevated nocturnal BP) and a higher rate of cardiovascular events, 28, 130, [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] but others failed to find such an association. [155] [156] [157] [158] [159] [160] In a large meta-analysis of data from prospective clinical stud- 
Proportion of patients with isolated hypertension (%)
Nighttime Daytime
Asian Chinese (n = 677) 10.9 4.9
Japanese (n = 1038) 10.5 6.0
Non-Asian
Eastern European (n = 854) 7.9 13.9
Western European (n = 3268) 
Cross-sectional;
Elderly hypertensives with ≥1 CV risk factor
-
In multiple linear regression analysis adjusted for age, gender and BMI, left insular cortex volume was significantly negatively associated with sleep SBP (P < .01) and positively with nocturnal SBP dipping (P < .05)
Nagai et al 2008 192
Cross-sectional; Unmedicated elderly hypertensives with ≥1 CV risk factor 55 -Nocturnal SBP dipping was significantly correlated with total brain matter volume (r-.323; P = .02) and Mini-Mental State Examination score (r = 0.402; P = .002). In multiple linear regression analysis adjusted for age, sex and BMI, sleep SBP (P = .009) was more significantly negatively associated with total brain matter volume than either 24-h (P = .035) or awake (P = .020) SBP
Hoshide et al 2007 191
Cross-sectional;
Adults undergoing ABPM
-
Multiple regression analysis showed that nocturnal SBP was independently associated with IMT (β = .10, P < .05) and RWT (β = . 28 Cross-sectional; Normotensives
74
-Non-dippers vs dippers had higher LV mass index (P < .05), relative wall thickness (P < .01) and levels of atrial (P < .01) and brain (P < .05) natriuretic peptides, and a greater prevalence of concentric hypertrophy (P < .05) Watanabe et al 1996 197 Cross-sectional, epidemiological survey; Untreated subjects (aged > 55 y)
70
-Women, but not men, showed a significant positive correlation between the amplitude or the rate of fall in nocturnal BP and the extent of periventricular hyperintensity on MRI (silent cerebral lesions) Kario et al 1996 198 Cross-sectional; Hypertensive out-pts aged ≥60 y (untreated for ≥1 m)
-
In pts with sustained HTN (n = 100), the extent of silent cerebrovascular damage was greater in extreme dippers and non-dippers than in those with a dipping pattern; there was a Jshaped relationship between nocturnal BP fall and brain MRI findings TA B L E 7 (Continued)
| Riser pattern/nocturnal hypertension
Reduction of nocturnal hypertension is an important part of achieving optimal 24-hour BP management and reducing or eliminating cardiovascular events. 56 In addition, nocturnal BP may be the most reproducible and reliable ABPM parameter for risk stratification. 36 The most recent analysis, based on the IDACO database, suggested that nocturnal SBP was a better predictor of cardiovascular risk (especially stroke risk) than dipping status or nocturnal SBP dipping ratio, possibly due to the good reproducibility of nighttime BP and the poor reproducibility of measures of dipping status. The authors concluded that nocturnal BP might be the most appropriate of the three parameters for risk stratification. 160 This is consistent with the findings of the Systolic Hypertension in Europe trial, in which nighttime SBP was the most accurate predictor of cardiovascular endpoints. 28 The riser pattern of nighttime BP is associated with a particularly poor prognosis with respect to the occurrence of stroke and cardiac events. 54 The negative impact of nocturnal hypertension on cardiovascular risk is particularly marked in the presence of diabetes mellitus. In a prospective study of hypertensive patients, the increase in cardiovascular risk associated with nocturnal hypertension vs normotension (nocturnal SBP ≥ 135 mm Hg vs <120 mm Hg) was 10.8-fold in patients with diabetes compared with 2.7-fold in those without diabetes. 156
| Extreme dipping
Extreme dipping (characterized by a ≧20% fall in nocturnal BP on ABPM) has been associated with a number of adverse outcomes, especially cerebrovascular events. Data from the JMS-ABPM study showed that elderly hypertensive patients with an extreme-dipper pattern were at increased risk of future clinical stroke events. 137 Similarly, another study showed that extreme dipping was associated with a significant increase in the risk of intracerebral hemorrhage compared to patients with a physiological fall in nighttime BP. 52 In a meta-analysis of data from 17 312 patients with hypertension across three continents, the Ambulatory Blood pressure Collaboration in patients with Hypertension (ABC-H) found that an extreme-dipper pattern was significantly associated with cardiovascular events only in unmedicated patients. 162
| Short-term BPV
Available evidence suggests that BPV is an important predictor of cardiovascular risk in patients with hypertension. 163 Therefore, reduction in BPV should be one of the goals of ABPM-directed antihypertensive treatment. Using ABPM in patients with hypertension, the risk of cardiovascular morbidity and mortality at 3-year follow-up was significantly higher in those with SBP variability of >15 vs ≤15 mm Hg (P < .01). 164 In hypertensive patients from Taiwan, reading-to-reading ARV in diastolic BP (ARVd) on ABPM was an independent predictor of cardiovascular mortality in patients with hypertension, after adjustment for conventional risk factors and both office and 24-hour SBP; similar (but weaker) associations were seen for ARV in SBP (ARVs). 165 The hemodynamic variable showing the most dominant independent association with ARV appears to be pulse wave reflection. 166 In the Ohasama study, which included 1542 individuals from a general Japanese population, those in the highest quintile for daytime SBP BPV (>18.8 mm Hg) had a significantly higher risk of cardiovascular death compared with subjects with SBP SD in the second quintile (11.5-13.9 mm Hg), and those in the highest quintile for nighttime BPV (>14.4 mm Hg) were at significantly higher risk of cardiovascular death compared to individuals with SBP BPV in the fourth quintile (11.8-14.4 mm Hg). 167 Although short-term BPV has been successfully used for risk stratification in population and cohort studies, its use in clinical practice is limited by a lack of accepted thresholds defining normal and pathologic shortterm BPV. 17
| ABPM parameters associated with target organ damage
| Morning surge
Markers of hypertensive heart disease, including increased left ventricular mass index (LVMI), left ventricular hypertrophy, and a lower A/E ratio (a measure of diastolic dysfunction), have all been associated with an exaggerated morning BP surge (Consensus Table   A10 ). 113, [168] [169] [170] Significant relationships have also been reported between increased morning BP surge and both increased carotid intima-media thickness (IMT) and microvascular dysfunction. 168, 171, 172 Vascular function, assessed using pulse wave velocity (PWV), has been shown to be impaired in patients with exaggerated morning BP surge. 173, 174 Histologic data suggest that exaggerated morning BP surge accelerates the formation of atherosclerotic plaques and induces plaque instability as a result of vascular inflammation. 175 In the JMS-ABPM study, morning BP surge in the highest quartile was significantly correlated with levels of the inflammatory marker highsensitivity C-reactive protein (hs-CRP). 114 Asymptomatic cerebral infarcts are important surrogate markers for the occurrence of stroke, especially in the presence of increased CRP levels. In the JMS-ABPM study, a significantly higher proportion of patients with vs without exaggerated morning BP surge and hs-CRP levels above the median had asymptomatic cerebral infarcts on brain magnetic resonance imaging. 176 These silent cerebral infarcts appear to be most closely related to the component of exaggerated morning BP surge associated with alpha-adrenergic activity. 177 Data on the role of morning BP surge in CKD are limited. One cross-sectional study in normotensive patients with newly diagnosed type 2 diabetes mellitus found that patients with microalbuminuria had significantly higher morning BP surge than patients without microalbuminuria, 178 although the correlation between increasing morning BP surge and albuminuria in another study was weak (r = .126; P < .05). 174 In addition, sleep-trough morning BP surge has been significantly associated with a higher resistive index (a marker of renal vascular resistance) in patients at risk of atherosclerosis. 179
| Non-dipping
A number of studies have shown blunted nighttime BP dipping to be associated with target organ damage. 53, [180] [181] [182] [183] [184] [185] In untreated normotensive Japanese subjects, those with a blunted fall in nighttime BP demonstrated signs of cardiac overload vs those who showed a normal fall in nighttime BP. 137, 183 A non-dipping nighttime BP pattern was associated with asymptomatic cerebrovascular disease in elderly hypertensive patients; both silent cerebral infarcts and deep white matter lesions were detected on brain magnetic resonance imaging. 53 Furthermore, kidney damage has been reported in patients with a non-dipping pattern of BP, 89, [186] [187] [188] [189] and a nondipping BP pattern was shown to be an important predictor of cardiovascular events and mortality in patients with end-stage renal disease. 190
| Riser pattern/nocturnal hypertension
In a Japanese study, patients with masked nocturnal hypertension (home BP < 135/85 mm Hg and ambulatory nocturnal BP ≥ 120/75 mm Hg) had greater IMT and relative wall thickness than normotensive individuals. 191 Elderly hypertensive non-dippers and risers have been shown to have atrophy of the brain and insular cortex. 192, 193 In addition, both the non-dipper pattern and the nocturnal hypertension are significantly associated with cognitive dysfunction and slow walking speed in elderly subjects. 168 In a Chinese population study, subjects found to have isolated 
| Extreme dipping
Extreme dippers have been shown to have more advanced deep white matter lesions on brain magnetic resonance imaging, reduced cerebral blood flow and increased PWV. [195] [196] [197] [198] In the CARDIA study of young normotensive subjects, extreme dippers, non-dippers and risers, defined by baseline ABPM, developed more advanced coronary calcification (detected by coronary computed tomography) during follow-up (≥10 years). Even after controlling for baseline covariates, the risk of having coronary calcium was four or more times greater in both extreme dippers and non-dippers/risers compared with normal dippers. 199
| Short-term BPV
When mean 24-hour BP was similar, hypertensive patients with greater BPV had an increased LVMI compared to those with lower BP variability. 200 In another study, the development of early carotid atherosclerosis was significantly increased in patients with SBP variability of >15 vs ≤15 mm Hg (P < .005). 164 Circadian hyper-amplitude tension (CHAT; defined as circadian amplitude exceeding the upper 95% prediction limit for clinically healthy peers matched by gender, age and ethnicity) was associated with increased LVMI in an analysis of 2039 untreated patients with hypertension. 201 In the very elderly, an increase in ambulatory BPV has been shown to be significantly associated with cognitive dysfunction, assessed using the Mini-Mental State Examination. 202 Even when ambulatory BP was well controlled in another study of elderly patients (mean age 78 years), increased ambulatory BPV (assessed using the standard deviation of ambulatory SBP)-but not average ambulatory BP-was significantly associated with cognitive dysfunction assessed using the Japanese version of the Montreal Cognitive Assessment. 203
| Antihypertensive treatment assessed by ABPM
In clinical practice, good BP control includes three components:
reducing 24-hour BP, maintaining normal circadian rhythm (dipper type), and suppressing exaggerated BPV (especially the morning surge; Figure 5 ); ABPM has the ability to determine all of these important parameters and therefore has a role in monitoring the BP-lowering effects of lifestyle modifications and antihypertensive therapy (Consensus Table A10 ). For example, the use of ABPM showed that nutritional advice combined with salt restriction was associated with a significant reduction in 24-hour SBP in treated Japanese patients with hypertension. 204 It is important to take sea- with less intensive therapy compared with treatment managed using office BP. 206 In addition, the proportion of primary care patients achieving target BP was higher when antihypertensive therapy was managed using ABPM compared with office BP (38% vs 12% in one study and 54% vs 37% in another). 207, 208 in patients with essential hypertension, and was more effective than lisinopril for decreasing morning BP and the morning surge in SBP. 215 Alpha-adrenergic and alpha/beta-adrenergic blockers are also effective for reducing the morning BP surge in hypertensive patients. In particular, nocturnal dosing of alpha-adrenergic blockers achieves peak effect in the mornings, providing greater BP reductions during these hours. In the Hypertension and Lipid Trial (HALT), bedtime administration of the alpha-1 blocker doxazosin predominantly reduced morning BP. 216, 217 In another study, morning BP and morning BP surge were reduced by bedtime dosing of doxazosin. 177 Sacubitril/valsartan (LCZ696) is a first-in-class angiotensin receptor neprilysin inhibitor (ARNI) that inhibits neprilysin and the angiotensin (AT 1 ) receptor, and has potential synergistic activity for cardiovascular protection. 218 ABPM studies showed that sacubitril/ valsartan effectively reduced 24-hour BP, including nocturnal BP, in both Western and Asian patients with hypertension. 219, 220 Data
show that Asian patients with hypertension may respond particularly well to this agent. [221] [222] [223] [224] [225] Sodium-glucose cotransporter-2 (SGLT2) inhibitors significantly reduce 24-hour ambulatory BP, with beneficial effects on both daytime and nighttime BP. 226, 227 This has been suggested to be a hemodynamic mechanism underlying the beneficial effects of SGLT2 inhibitors on heart failure in patients with diabetes. 228 The ability of SGLT2 inhibitors to reduce 24-hour BP in salt-sensitive patients 227 suggests that these agents may be suited to the management of in Japanese patients with hypertension. [229] [230] [231] [232] These studies also showed that bedtime antihypertensive dosing has similar effectiveness to morning dosing with respect to control of morning and nighttime BP. If BP is not controlled by dual combination therapy, the triple therapy combination of a RAS inhibitor, a CCB, and a diuretic is the best option in both Asians and Westerners.
Catheter-based renal sympathetic denervation is a new devicebased strategy that has recently been introduced for the manage- the results of the first randomized trial to include a sham operation arm showed no significant difference between the renal denervation and sham operation groups with respect to the reduction in 24-hour SBP. 236 Nevertheless, analysis of data from that study and a randomized trial conducted in Japan showed that morning BP, nighttime BP, the 2-hour average morning BP, and maximum and moving peak BP were reduced to a greater extent in the renal denervation group vs controls (sham operation or observation only). 237 Certainly, ABPM has been included as an important assessment tool in trials evaluating renal denervation for the treatment of resistant hypertension. [238] [239] [240] Further research is required to determine whether renal denervation can effectively and consistently control 24-hour BP. It is currently not recommended as a routine procedure in the latest European or US guidelines. 22,23
| Positioning of ABPM in hypertension guidelines
There is a consistent message that ABPM should be used as a diagnostic tool to evaluate hypertension. Guidelines from North America, 37, 47 Europe, 16, 17 Japan, 21 and China 48 recommend ABPM as the best technology for measuring BP to facilitate the diagnosis of hypertension, and its use in individuals with elevated BP (≥140/90 mm Hg) detected by any means. A summary of recommendations for the use of ABPM in major guidelines is provided in Table 8 . No current guidelines provide specific recommendations about the use of ABPM to facilitate the initiation and monitoring of antihypertensive therapy, although emphasis on out-of-office BP measurement (ABPM and HBPM) in clinical practice has increased in the latest revisions of major guidelines. 22, 23 The most comprehensive guidance on the use of ABPM is provided by the ESH position paper, 17 although the main focus is diagnostic use rather than as a method for monitoring the initiation and effectiveness of antihypertensive therapy. This paper does note that the frequency of repeat ABPM for evaluation of antihypertensive medication effectiveness should depend on the severity of hypertension and the response to treatment, being more frequent when hypertension is more severe and in the presence of target organ damage and comorbidities, and less frequent in mild, uncomplicated hypertension-patient preference and physician discretion are suggested as important. 17 For higher risk patients, it has been 
| New ABPM indicators and telemedicine
ABPM has traditionally been considered the gold standard for determination of out-of-office BP. However, recent technology developments suggest that use of information and communication technology (ICT)-based devices, which perform automatic, fixed-interval BP measurement during sleep and store or transmit the data (telemedicine), could facilitate a novel approach to patient management. 90 In addition, there are a number of other ICT-based devices that provide important data for optimization of patient management.
These in Thailand, and three in Taiwan; Table S1 ). However, the use of ABPM in clinical practice is influenced by more than just device availability. Other factors that play a role in the decision to use ABPM include cost/reimbursement, patient engagement, physician knowledge and attitude, training/education of both patient and physician, and available resources (both human and financial).
Issues such as cost (to the health care system and/or the patient) and practicalities (including scattered populations) will be more of a barrier in developing countries.
A survey conducted in Singapore showed that although nearly three-quarters of physicians who responded said they would recommend ABPM to their patients, only 27% of patients overall were actually given a recommendation for ABPM. 244 The most commonly Region-wide strategies are needed to improve access to APBM devices, provide physician training, and develop suitable education materials to facilitate more widespread use of ABPM in Asia. Therefore, ABPM may be particularly useful in Asian populations, improving patient management and the efficient allocation of treatment and health care resources. Abbreviations: ABPM, ambulatory blood pressure monitoring; BP, blood pressure; BPV, blood pressure variability. 
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